Nogle af disse tilfælde var livstruende og med en fatal udgang til trods for, at der var taget forholdsregler.
In clinical studies approximately 5% of subjects receiving abacavir develop a hypersensitivity reaction; some of these cases were life-threatening and resulted in a fatal outcome despite taking precautions.